Literature DB >> 1227359

[10 cases of giant lumbo-sacral neurinoma].

J B Piera, J Durand, S Pannier, G Guiot, A Grossiord.   

Abstract

Among giant tumours of the cauda equina, apart from ependymomas, neurinomas merit a special place. Depending on their site, they give rise to severe lumbar pain or root pain, with, almost constantly, aggravation during the night. X ray suggests the diagnosis when one finds displacement of the bone without inflammation, a regular bony defect, well-limited and asymmetric, and when the tumour is frequently prolonges in several directions across the bony orifices, sometimes giving a very large paravertebral mass which requires a double approach during surgery. The prognosis of isolated neurinomas is excellent, with disappearance of the pain immediately after operation, regression of the neurological signs or, at any rate, stabilisation when the latter are important. As far as the problem of spinal stability is concerned, this has been solved by sufficient spontaneous bony reconstruction.

Entities:  

Mesh:

Year:  1975        PMID: 1227359

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  4 in total

1.  One-stage resection of giant invasive thoracic schwannoma: case report and review of literature.

Authors:  Edison P Valle-Giler; Juanita Garces; Roger D Smith; Wale A R Sulaiman
Journal:  Ochsner J       Date:  2014

Review 2.  Giant schwannoma of the cauda equina without neurological deficits -- case report and review of the literature.

Authors:  Jürgen Piek
Journal:  Wien Klin Wochenschr       Date:  2010-10-22       Impact factor: 1.704

3.  Giant lumbosacral schwannoma in a child.

Authors:  Rashim Kataria; Dhruba Jyoti Kurmi; Jayanti Mehta; Virendra Deo Sinha
Journal:  J Pediatr Neurosci       Date:  2012-05

4.  The management of sacral schwannoma: report of four cases and review of literature.

Authors:  Chandhanarat Chandhanayingyong; Apichat Asavamongkolkul; Nittaya Lektrakul; Sorranart Muangsomboon
Journal:  Sarcoma       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.